Artemis Therapeutics Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Brightman Almagor Zohar & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -25.00% | 0.00% | -58.33% |
1st Jan change | Capi. | |
---|---|---|
-58.33% | 3.36M | |
+9.69% | 115B | |
+11.59% | 106B | |
-2.59% | 21.96B | |
-13.23% | 21.87B | |
-5.29% | 19.21B | |
-4.10% | 18.08B | |
-38.57% | 17.71B | |
+6.72% | 14.32B | |
+34.21% | 12.42B |
- Stock Market
- Equities
- MNKA Stock
- News Manuka, Inc.
- Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt